Results 101 to 110 of about 210,000 (180)
Sideroblastic anemia: An underdiagnosed rare disease
Swetha Palla +5 more
doaj +1 more source
SIDEROBLASTIC ANAEMIA–A HITHERTO UNRCCGNIZED CAUSE OF UNEXPLAINED ANAEMIA
Objective: To assess the clinicopathological heterogeneity of sideroblastic anemia disorders characterized by the presence of ring sideroblasts in the bone marrow. Study Design: Descriptive study. Place and Duration of Study: Study was conducted
Kamran Nazir Ahmad +5 more
doaj
Biallelic mutations in the SARS2 gene presenting as congenital sideroblastic anemia. [PDF]
Colin E +13 more
europepmc +1 more source
A New Gain-of-Function NLRP1 Variant Is Associated with Inflammasome Activation and Disease Severity in SLC25A38 Congenital Sideroblastic Anemia Case Report. [PDF]
Sánchez-Villalobos M +11 more
europepmc +1 more source
X-linked sideroblastic anemia (XLSA) is caused by mutations in the erythroid-specific 5-aminolevulinic acid synthase (ALAS2) gene. An elderly woman who presented with an acquired sideroblastic anemia is studied.
CAZZOLA, MARIO +5 more
core
Azacitidine is a potential therapeutic drug for pyridoxine-refractory female X-linked sideroblastic anemia. [PDF]
Morimoto Y +11 more
europepmc +1 more source
COVID-19 associated respiratory failure complicating a pericardial effusion in a patient with sideroblastic anemia. [PDF]
Sayad E +5 more
europepmc +1 more source
M, Tsukada, M, Shimizu
openaire +4 more sources
Erworbene vitamin-B₆-responsive, primäre sideroblastische Anämie, ein Enzymdefekt der Hämsynsthese
The activity of delta-aminolevulinic acid synthetase (ALAS), the rate-limiting enzyme in heme synthesis, has been found to be markedly reduced (13% of controls) in erythroblasts of a patient with acquired, primary sideroblastic anemia.
Giger, U. +3 more
core

